Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1312139 | 0.92 | MEN1 (0.42) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL102019 | 0.89 | MEN1 (0.47) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL101012 | 0.88 | MEN1 (0.37) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL5432916 | 0.85 | MEN1 (0.33) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL10490624 | 0.76 | MEN1 (0.32) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL777074 | 0.70 | — | — | |
| SCHEMBL1312705 | 0.70 | CYP3A4 (0.50) | MEN1ALDH1A1CYP3A4MAPTHPGD | |
| SCHEMBL10611655 | 0.68 | NOTUM (0.31) | — | |
| SCHEMBL1312947 | 0.67 | CYP3A4 (0.47) | MEN1ALDH1A1CYP3A4MAPTHPGD | |
| SCHEMBL102072 | 0.67 | CYP3A4 (0.39) | ALDH1A1CYP3A4HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084988-A | Polymerization monomer for preparing beta-1, 3 glucan and polymerization method | 山东大学 | 2024-05-28 | — | — | CN | claimed |
| WO-2024081372-A1 | PROCESSES FOR THE PREPARATION OF THE AGENT-LINKER CONJUGATE CL2A-SN-38 AND THE IMMUNOCONJUGATES SACITUZUMAB GOVITECAN AND LABETUZUMAB GOVETICAN | GILEAD SCIENCES, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| EP-4140988-A1 | L-VALINATE OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | Merck Serono S.A. (CH) | 2023-03-01 | — | — | EP | claimed |
| EP-3720854-B1 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | BRACCO IMAGING SPA (IT) | 2021-04-21 | — | — | EP | claimed |
| US-10822371-B2 | Solid phase synthesis of NIR fluorescent probe | BRACCO IMAGING S.P.A. (IT) | 2020-11-03 | — | — | US | claimed |
| EP-3720854-A1 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | Bracco Imaging SpA (IT) | 2020-10-14 | — | — | EP | claimed |
| US-20200317722-A1 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | BRACCO IMAGING S.P.A. (IT) | 2020-10-08 | — | — | US | claimed |
| CN-111356691-A | Solid phase synthesis of NIR fluorescent probes | 伯拉考成像股份公司 | 2020-06-30 | — | — | CN | claimed |
| WO-2019110639-A1 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | BRACCO IMAGING SPA (IT) | 2019-06-13 | — | — | WO | claimed |
| EP-3400217-A1 | L-VALINATE OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF | Merck Serono S.A. (CH) | 2018-11-14 | — | — | EP | claimed |
| WO-2006012425-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2006-02-02 | — | — | WO | claimed |
| US-20050107600-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | CORIXA CORPORATION, A CORPORATION OF THE STATE OF DELAWARE (US) | 2005-05-19 | — | — | US | claimed |
| EP-1521762-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040267007-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor | CORIXA CORPORATION | 2004-12-30 | — | — | US | claimed |
| WO-2004005308-A2 | PROCESSES FOR THE PRODUCTION OF AMINOALKYL GLUCOSAMINIDE PHOSPHATE AND DISACCHARIDE IMMUNOEFFECTORS, AND INTERMEDIATES THEREFOR | CORIXA CORPORATION (US) | 2004-01-15 | — | — | WO | claimed |
| US-6355615-B1 | CYCLIC POLYAMIDEESTER COPOLYMERS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-03-12 | — | — | US | claimed |
| EP-0648220-A1 | DEUTERATED NUCLEOSIDES | CHATTOPADHYAYA, Jyoti (SE) | 1995-04-19 | — | — | EP | claimed |
| WO-1993025566-A1 | DEUTERATED NUCLEOSIDES | CHATTOPADHYAYA JYOTI (SE) | 1993-12-23 | — | — | WO | claimed |
| US-4175185-A | ESTERIFICATION, IMINOHALOGENATION, ETHERIFICATION, HYDROLYSIS, DEESTERIFICATION | MEIJI SEIKA KAISHA LTD. (JP) | 1979-11-20 | — | — | US | claimed |
| US-3996043-A | HERBICIDES | STAUFFER CHEMICAL COMPANY (US) | 1976-12-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317722-A1 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | MKI67, SSTR5, AURKA | MEN1 1675/4885ALDH1A1 3804/4885TP53 11/4885 |
| US-20040267007-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor | DDOST, STT3A, STT3B | MEN1 3860/4885ALDH1A1 1755/4885TP53 3230/4885 |
| US-20050107600-A1 | Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor | DDOST, AGL, GALE | MEN1 3756/4885ALDH1A1 1633/4885TP53 2990/4885 |
| US-10822371-B2 | Solid phase synthesis of NIR fluorescent probe | MKI67, SSTR5, AURKA | MEN1 1675/4885ALDH1A1 3804/4885TP53 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.